Selank 10mg

What is Selank (10 mg)?

Selank is a synthetic peptide studied in neurobiology and immunology research. It is a heptapeptide analog derived from the naturally occurring tuftsin peptide, which plays a role in immune signaling processes. In laboratory studies, Selank has been investigated for its potential effects on cellular communication systems associated with neurological and immune pathways. As a modified form of tuftsin, this peptide is being explored by researchers for its interactions with biological signaling networks. These investigations are ongoing and aim to enhance the understanding of peptide-based regulatory mechanisms.

What are the key features of Selank (10 mg)?

• Peptide Type: Synthetic heptapeptide derived from tuftsin
• CAS Number: 129954-34-3
• Sequence Length: 7 amino acids (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
• Subcategory: Brain, Cognitive & Nootropic Peptides
• Molecular Weight: 751.878 g/mol
• Chemical Formula: C₃₃H₅₇N₁₁O₉
• Purity: Typically ≥95–99%, confirmed through analytical testing
• Format: Lyophilized powder in sterile research vials
• Research Focus: Neurobiological signaling and immune-related peptide pathways
• For Laboratory Research Use Only

How is Selank (10 mg) synthesized?

Selank is produced using solid-phase peptide synthesis (SPPS), a widely-used method for manufacturing research peptides. In this process, protected amino acids are sequentially added to a growing peptide chain anchored to a solid support, allowing precise assembly of the seven-amino-acid sequence that forms Selank. After synthesis, the peptide is purified to remove incomplete sequences and by-products. High-performance liquid chromatography (HPLC) is commonly used to verify purity, while mass spectrometry (MS) confirms the expected molecular weight and structure. These methods ensure that the peptide meets quality standards for scientific investigation. Following purification and testing, the peptide is lyophilized into a stable powder form suitable for storage and laboratory use.

What is Selank (10 mg) being studied for? What are its possible benefits?

Selank has been studied in several areas of experimental research on neurological signaling and immune activity. As it is derived from the tuftsin peptide framework, scientists have explored its potential influence on biological communication systems involved in both neural and immune pathways. Research areas include:

• Neurochemical signaling and central nervous system activity
• Immune system modulation and peptide signaling
• Stress-related biological responses in experimental models
• Regulation of inflammatory signaling pathways
• Interactions between peptides and neurotransmitter systems

These research areas aim to improve the understanding of how short peptides influence complex biological networks. While laboratory observations provide insights into peptide behavior, these findings are still under investigation and should not be interpreted as established therapeutic outcomes.

How does Selank (10 mg) work in research studies?

In experimental settings, Selank is studied to assess its potential effects on cellular signaling pathways in the nervous and immune systems. Peptides function as biological messengers that help coordinate communication between cells, tissues, and regulatory pathways. Researchers have investigated whether Selank can affect biochemical signaling networks associated with neurotransmitter activity and immune responses. Laboratory studies often focus on how the peptide may influence gene expression, protein activity, or signaling molecules involved in cellular communication. Since Selank is structurally related to tuftsin, research also explores how modifications to this peptide framework may alter biological stability or signaling interactions during experimental observation.

What dosing information exists for Selank (10 mg)?

Dosing information for Selank comes from preclinical or experimental research rather than standardized human dosing guidelines. In these studies, peptide concentrations are typically selected based on the research objectives and biological model under investigation. Some experimental studies involving Selank have explored concentrations ranging from 10–100 µg/kg in animal models or similar ranges in controlled laboratory settings. These studies aim to observe biological responses and pharmacokinetic behavior under experimental conditions. It is important to note that there are no universally accepted human dosing guidelines for Selank. Researchers determine appropriate concentrations according to their experimental protocols and institutional research standards.

How should Selank (10 mg) be stored and handled?

Proper storage is essential to maintain peptide stability during laboratory use. Selank, supplied as a lyophilized powder, should be stored at –20 °C in a sealed container protected from light and moisture. These conditions help preserve the peptide's structural integrity before reconstitution. Once reconstituted with an appropriate laboratory solvent, the peptide solution is typically stored at 2–8 °C for short-term use. Reconstituted solutions should be handled using sterile laboratory techniques and used within the stability period recommended by the supplier. Repeated freeze-thaw cycles should be avoided, as they may affect peptide stability. Following standard laboratory storage practices helps maintain consistent research conditions.

Where can I read more research about Selank (10 mg)?

1. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. Published 2016 Feb 18. doi:10.3389/fphar.2016.00031
2. Kolik LG, Nadorova AV, Antipova TA, Kruglov SV, Kudrin VS, Durnev AD. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019;167(5):641-644. doi:10.1007/s10517-019-04588-9
3. Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neurosci Med. 2013;4(4):223-252. doi:10.4236/nm.2013.44035. https://pdfs.semanticscholar.org/2a11/334f12fff603f90a83ef1127e3192ca186b2.pdf
4. Zozulya AA, Kost NV, Yu Sokolov O, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001;131(4):315-317. doi:10.1023/a:1017979514274

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.